Articles from NovAccel Inc.

TSUCHIURA, Japan, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Following the Company’s September 9 announcement in Japan, NovAccel, Inc. (Headquarters: Ibaraki Prefecture, hereinafter “NovAccel”), a company developing RiSA (Radio-isotope production Superconducting Accelerator), a proprietary compact superconducting accelerator for the manufacturing of medical radioisotopes, today announced the establishment of its wholly owned U.S. subsidiary, NovAccel Isotopes Inc., as part of its strategy to expand in North America and support the development of a reliable global supply of actinium-225 (Ac-225).